Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Finkelstein

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cellsPaul A Antony, Ciriaco A Piccirillo, Akgül Akpinarli, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation OncologistsElizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Journal of the National Cancer Institute|October 19, 2014
Combining targeted agents with modern radiotherapy in soft tissue sarcomasPhilip Wong, Peter Houghton, David G Kirsch, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologistsDian Wang, Walter Bosch, David G Kirsch, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Nature Communications|March 19, 2026
Behavioral shifts mask the success of legislation and outreach for endangered species recoveryVictoria J Bakker, Daniel F Doak, Alacia Welch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cellsPaul A Antony, Ciriaco A Piccirillo, Akgül Akpinarli, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation OncologistsElizabeth H Baldini, Ross A Abrams, Walter Bosch, et al.
Journal of the National Cancer Institute|October 19, 2014
Combining targeted agents with modern radiotherapy in soft tissue sarcomasPhilip Wong, Peter Houghton, David G Kirsch, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2011
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologistsDian Wang, Walter Bosch, David G Kirsch, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Nature Communications|March 19, 2026
Behavioral shifts mask the success of legislation and outreach for endangered species recoveryVictoria J Bakker, Daniel F Doak, Alacia Welch, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Pageof 18